Recent Headlines
Bencos Shifts Website Domain from .in to .com
Bencos Research Solutions Pvt. Ltd. is now available at www.bencoslife.com. - August 09, 2011 - Bencos Research Solutions
Tracking Environmental Monitoring Trends Crucial to Regulatory Compliance, OsoBio Expert Says
A microbiology laboratory manager at OSO BioPharmaceuticals Manufacturing, LLC, has authored a chapter on environmental monitoring trends for an industry reference manual. Kim Van Antwerpen wrote a chapter for “Environmental Monitoring: A Comprehensive Handbook (vol. 5)” edited by... - July 30, 2011 - OSO BioPharmaceuticals Manufacturing, LLC
Raybiotech Launches Risk-Free Trial Program for ELISA Kits
RayBiotech, Inc., has just launched a Risk-Free Trial on its ELISA kits, stipulating that if a researcher is unsatisfied with the performance of any RayBio® ELISA, EIA, or phosphorylation ELISA, they can receive a full product refund or credit. - July 22, 2011 - RayBiotech, Inc
AnaSpec Releases Anti-LL-37
AnaSpec is pleased to announce the release of a new anti-LL-37. Rabbit Anti-human Cathelicidin LL-37 polyclonal antibody was raised against a synthetic peptide from a sequence found within 134-170 amino acid residues (LL-37) of the LL-37 precursor human cationic antimicrobial protein, hCAP-18... - July 17, 2011 - AnaSpec, EGT Group
AnaSpec Expands SensoLyte® MMP Assay Kits Collection
Since its introduction, AnaSpec, EGT Group’s product line of SensoLyte® 520 MMP Assay Kits has become the new standard in MMP assay sensitivity. These fluorescence resonance energy transfer (FRET)-based assay kits utilizing the 5-FAM/QXL™ 520 are some of the most sensitive and... - July 17, 2011 - AnaSpec, EGT Group
AnaSpec Specializes in Custom Peptide Synthesis
Since 1993, AnaSpec has assisted scientists in the design and synthesis of >50,000 peptides. As a result, AnaSpec's combined knowledge and expertise provide premium solutions to its customers. AnaSpec routinely completes difficult peptide synthesis such as synthesis of long peptides... - July 15, 2011 - AnaSpec, EGT Group
OSO BioPharmaceuticals Receives DEA Approval to Handle Controlled Substances
OSO BioPharmaceuticals Manufacturing, LLC, has been granted research and analytical licenses by the U.S. Drug Enforcement Administration (DEA) to handle Schedule II through V controlled substances. - June 24, 2011 - OSO BioPharmaceuticals Manufacturing, LLC
AnaSpec Offers Custom Assay Development Service
AnaSpec, EGT Group, provider of the long wavelength, ultra-sensitive SensoLyte® assay kits, is pleased to offer custom service for the development of assays. The long wavelength of SensoLyte® protease assays, many of which utilize the 5-FAM/QXL™ 520 and HiLyte Fluor™... - June 23, 2011 - AnaSpec, EGT Group
AnaSpec Highlights Anb-Wang Resin
Colorimetric based Peptide-p-Nitroanilide conjugates (peptide-pNAs), with absorbance at approximately 408 nm, have historically been and are still widely used substrates for the study of protease activity. However, the preparation of peptide-pNA presents technical challenges. The amino group of pNA... - June 23, 2011 - AnaSpec, EGT Group
Scisense Offers Educational Webinar “Exploring Synergies Between Echo and Pressure-Volume Systems” Featuring Dr. Kim Connelly
Webinar attendees will learn both the advantages and challenges of echocardiography and PV loop analysis. - June 04, 2011 - Scisense Systems Inc.
CELFIX Cosmeceuticals Announces Launch of DNA iQuad Infusion Total Eye Complex
Carefree Skincare is focused on developing and providing consumers with innovative and highly efficacious anti-aging products that enhance the health and appearance of aging skin. Products are marketed under the CELFIX Cosmeceuticals brand name. The CELFIX DNA focused skincare line’s primary focus is in providing topical skincare utilizing DNA Repair Enzyme Technology. - June 02, 2011 - CELFIX Cosmeceuticals
AnaSpec Introduces DPPIV Assay Kit
AnaSpec, EGT Group is pleased to introduce a new long wavelength fluorimetric assay kit for determining Dipeptidyl Peptidase IV (DPPIV) activity, the SensoLyte® Rh110 DPPIV Assay Kit. This kit contains a substrate that emits in the green range of 520 nm when cleaved by DPPIV. The kit provides a... - May 27, 2011 - AnaSpec, EGT Group
AnaSpec Introduces Speedy 28-Day Custom Polyclonal Antibody Service
When traditional protocols can take almost 90 days, the wait for high-quality custom polyclonal antibodies can be excruciating. AnaSpec is pleased to introduce the Speedy 28-day custom polyclonal antibody service. Leveraging proven technology from Eurogentec, AnaSpec's parent company, this protocol... - May 27, 2011 - AnaSpec, EGT Group
AnaSpec Introduces Anti- β-Amyloid
AnaSpec, Eurogentec Group is pleased to announce the release of two new mouse monoclonal antibodies specific for β-Amyloid (1-40) & (1-42). These two antibodies are of the IgG1 subtype and do not cross-react with each other at concentrations up to 50 ng/ml when tested in sandwich ELISA. - May 27, 2011 - AnaSpec, EGT Group
AnaSpec Offers High-Throughput Dispensing Service
AnaSpec, EGT Group is pleased to offer high-throughput dispensing service. Their commitment to supply the life science community with simple, affordable and innovative solutions has resulted in this service: bringing the advantages of automation within everyone’s reach. The fully equipped... - May 27, 2011 - AnaSpec, EGT Group
AnaSpec Highlights MMP Inhibitors
AnaSpec, Eurogentec Group, is pleased to release 11 MMP inhibitors to complement their wide offering of MMP SensoLyte® 520 and 490 fluorimetric kits, colorimetric kits, recombinant proteins, and Z-Fish™ antibodies (antibodies specific for zebrafish). These MMP inhibitors are small... - May 25, 2011 - AnaSpec, EGT Group
Scisense Offers an Educational Webinar Titled "Peer-Review Expectations of PV Loop Data" Featuring Dr. Marc Feldman (MD, FACC), University of Texas
Webinar attendees will gain insights about validating PV loop data. - May 21, 2011 - Scisense Systems Inc.
GenScript Launches eStainTM 2.0 Protein Staining System
Internationally recognized Contract Research Organization (CRO) GenScript USA Incorporation has launched eStainTM 2.0 Protein Staining System to replace the original eStainTM System. The eStainTM 2.0 System provides fast and convenient protein gel staining in 7 minutes or less and has improved the... - May 18, 2011 - GenScript USA Inc.
OSO BioPharmaceuticals Manufacturing LLC Honored for Corporate Efforts to Protect Integrity of Rio Grande
OSO BioPharmaceuticals Manufacturing, LLC, has received the Pollution Prevention Award for its efforts to protect water quality in the Rio Grande River. The honor was awarded by the Albuquerque Bernalillo County Water Utility as part of its Pollution Prevention Program (P2 Program). The P2... - May 13, 2011 - OSO BioPharmaceuticals Manufacturing, LLC
Eagle Biosciences Announces the Launch of Mouse Monoclonal Antibody Isotyping ELISA Kit
Eagle Biosciences introduces a simple ELISA where up to 12 individual samples can be assayed for heavy chain anti-IgG1, IgG2a, IgG2b, IgG3, IgA, and IgM as well as light chain kappa and lambda in one 96-well ELISA plate. - May 11, 2011 - Eagle Biosciences, Inc.
GenScript Continues Deploying New Websites in Europe
GenScript USA Inc. has launched new websites at www.genscript.fr in France and at www.genscript.es in Spain to offer easier access for local French and Spanish searchers. - May 01, 2011 - GenScript USA Inc.
Scisense, Inc. is Hosting a Hands-on Workshop Clinic to Assess Cardiac Function
Studying Pressure Volume Loops Using Large-Animal Models: New Insights, Latest Advancements in PV Loop Technology, and Hands-on Experience. This workshop is scheduled for September 2011. - April 28, 2011 - Scisense Systems Inc.
AnaSpec Introduces Industry’s First Zebrafish Specific Antibodies - Z-FishTM Anti-Lysozyme
AnaSpec, Eurogentec Group is pleased to be the first in the industry to establish a new product line of zebrafish specific (Z-Fish™) antibodies to support the increasing needs of researchers. In collaboration with the University of Utah, Salt Lake City, Utah, AnaSpec's Z-Fish™... - April 13, 2011 - AnaSpec, EGT Group
GenScript Will Launch Services with GANP® Technology for World Wide Market Excluding Japan
GenScript Corporation signed a worldwide (excluding Japan) non-exclusive license agreement with TransGenic Inc. through which GenScript Corporation is authorized to use GANP® mice from TransGenic Inc. to produce high-affinity antibodies to scientists. - March 25, 2011 - GenScript USA Inc.
Science of Cardiac Function Assessment Using Pressure Volume Loops Web Seminar
Online Educational Web Seminar to Explain the Pressure and Volume Changes During the Cardiac Cycle. Scisense Inc. hosts Dr. Richard Klabunde, author of “Cardiovascular Physiology Concepts,” to explain the significance of pressure and volume changes during the cardiac cycle on cardiovascular function, covering relationships such as ESPVR, PRSW, and EDPVR. - March 23, 2011 - Scisense Systems Inc.
GenScript Launches New Website in Germany
GenScript USA Inc. has launched a new website at www.genscript.de in Germany to offer easier access for local German searchers. - March 16, 2011 - GenScript USA Inc.
BioAtla and Charles River Partner for Integrated Biological Service for Preclinical Development
BioAtla and Charles River have recently partnered to create an integrated biological service for antibodies and other protein therapeutics designed to accelerate drug development for customers from the earliest stages of discovery all the way through IND. - March 09, 2011 - BioAtla
AnaSpec Introduces Cherry™Express T7 Protein Expression Kits
AnaSpec, Eurogentec Group is pleased to introduce CherryTMExpress T7 Protein Express Kits from Eurogentec. The Cherry™Express kit allows direct visualization through the whole process of T7 protein expression, production and purification without the need for any special requirements or... - February 24, 2011 - AnaSpec, EGT Group
AnaSpec Showcases Premium Quality of Fluorescent Nucleic Acid Probes
AnaSpec is pleased to showcase a variety of premium quality stains, including cell-impermeant and cell-permeant nucleic acid stains. The detection of nucleic acids is important for many life science research tasks, such as sequencing, cDNA synthesis and cloning, RNA transcription and transfection. - February 24, 2011 - AnaSpec, EGT Group
OSO BioPharmaceuticals to Sponsor Forum on Subcutaneous Biologic Drug Delivery Trends and Best Practices at DCAT Week
The 2011 DCAT Week Biologics Forum will present regulatory and pharmaceutical industry leaders discussing current requirements, trends and best practices for subcutaneous biologic drug delivery systems. - February 24, 2011 - OSO BioPharmaceuticals Manufacturing, LLC
AnaSpec Signs Distribution Agreement with In Vitr
AnaSpec, Eurogentec Group and In Vitro have announced a non-exclusive distributor agreement that will allow In Vitro and its European branches to distribute AnaSpec’s catalog and custom products for Peptides, Fluorescent Dyes, Antibodies, Assay Kits, and Amino Acids throughout Europe. In... - February 18, 2011 - AnaSpec, EGT Group
AnaSpec Offers α & β-Synuclein Recombinant Proteins
AnaSpec, Eurogentec Group, is pleased to offer two recombinant proteins for use in Neurodegenerative Disease Research, α-synuclein (SNCA) and β-synuclein (SNCB). Both α-synuclein and β-synuclein are expressed and purified from E. coli. α-Synuclein is a 140-amino acid... - February 18, 2011 - AnaSpec, EGT Group
AnaSpec Introduces SensoLyte® SIRT2 Assay Kits Fluorimetric
Expanding on their offerings of long wavelength, highly sensitive SIRT assays, AnaSpec, Eurogentec Group, is pleased to release 2 assay kits for SIRT2, the SensoLyte® 520 FRET SIRT2 Assay Kit and the SensoLyte® Green SIRT2 Assay Kit. The substrate found in the SensoLyte® 520 FRET SIRT2... - February 16, 2011 - AnaSpec, EGT Group
Apogen for Anti-Virus, New Dietary Supplement by FEBICO
FEBICO invested almost 10 years of R&D in the self cultivation of their organic spirulina FEM101 to extract the purest water soluble Apogen microalgae protein. In a research collaborated with the Graduate Institute of Biomedical Sciences of Chang Gung University in 1999, they found that the... - February 08, 2011 - Far East Bio-Tech Co., Ltd
Oncolytics Biotech® Inc. Announces 2-Arm, Randomized Phase II Pancreatic Cancer Study
Oncolytics Biotech Inc. (“Oncolytics”) announced that the Cancer Therapy Evaluation Program, Division of Cancer Treatment and Diagnosis, U.S. National Cancer Institute (NCI), which is part of the National Institutes of Health, has agreed to sponsor a 2-Arm randomized Phase II study of... - February 04, 2011 - Oncolytics Biotech
Susan Schniepp, VP of Quality at OSO BioPharmaceuticals, Elected to PDA Board of Directors
Susan Schniepp, vice president of quality at OSO BioPharmaceuticals Manufacturing, LLC, has been elected to the board of directors at the Parenteral Drug Association (PDA). Schniepp has enjoyed a long and productive relationship with the PDA. In addition to serving on numerous committees and being... - January 28, 2011 - OSO BioPharmaceuticals Manufacturing, LLC
AnaSpec Introduces Industry’s First Fluorimetric Assay - SensoLyte® Cathepsin G Kits
AnaSpec, Eurogentec Group, is pleased to announce the release of the industry's first fluorimetric kits for Cathepsin G, the SensoLyte® 520 Cathepsin G Assay Kit and SensoLyte® Rh110 Cathepsin G Assay Kit. These long-wavelength, homogeneous assays are ideal for the screening of enzyme... - January 22, 2011 - AnaSpec, EGT Group
AnaSpec Offers PEGylated Amino Acids
AnaSpec, Eurogentec Group, is pleased to highlight their wide collection of Fmoc- and Boc-protected PEGylated amino acids for PEGylated peptides synthesis. PEGylation has become a well-accepted method for the delivery of biopharmaceuticals-especially peptide and protein drugs.1-4 Simple... - January 22, 2011 - AnaSpec, EGT Group
OSO BioPharmaceuticals Taps Craig Mastenbaum to Lead West Coast Business Development
OSO BioPharmaceuticals Manufacturing, LLC, has named Craig Mastenbaum director of new business development for its West Coast market. Mastenbaum brings to OsoBio more than 30 years of leadership experience in clinical and contract liquid, lyophilized, ampule and syringe product manufacturing. Most... - January 21, 2011 - OSO BioPharmaceuticals Manufacturing, LLC
GenScript Corporation Has Installed the First BiacoreTM T200 Biosensor in the World
GenScript Corporation and GE Healthcare Life Sciences China together held an opening ceremony on Dec 22nd 2010 in Nanjing China, to celebrate the successful installation of the first unit of BiacoreTM T200 instrument in the world. To an audience of primarily research scientists from both big... - January 19, 2011 - GenScript USA Inc.
Oncolytics Biotech® Inc. Announces Opening of Enrollment in U.S. Phase I Colorectal Cancer Study
The principal investigator of the new colon cancer trial using Reolysin is Dr. Sanjay Goel of the Montefiore Medical Center at The Albert Einstein College of Medicine in New York. - January 13, 2011 - Oncolytics Biotech
AnaSpec Introduces Industry’s First FRET-Based - SensoLyte® Green Elastase Assay Kits
AnaSpec, Eurogentec Group is pleased to introduce the SensoLyte® Green Elastase Assay Kit - the first FRET-based Elastase activity assay kit in the industry. This kit employs a natural substrate, elastin that is labeled with the 5-FAM fluorophore and the QXL™ 520 quencher. Proteolytic... - December 30, 2010 - AnaSpec, EGT Group
AnaSpec Expands Anti-GFP Collection – mAb & Chicken Polyclonal Antibodies
AnaSpec is pleased to expand their GFP antibodies offerings. The new GFP antibodies include two monoclonals raised in mouse and a third, a polyclonal raised in chicken. Purified green-fluorescent protein (GFP) was used as antigen. Antibody reactivity was confirmed by ELISA and specificity was... - December 30, 2010 - AnaSpec, EGT Group
AnaSpec Offers Double-Dye Oligo Synthesis Service
AnaSpec, Eurogentec Group is pleased to highlight our Double-Dye Oligo Synthesis Service. With over 20 years expertise of oligonucleotide synthesis, and Eurogentec production facilities in San Diego, California and Liege, Belgium, AnaSpec now offers the largest number of fluorescent reporters and... - December 22, 2010 - AnaSpec, EGT Group
AnaSpec Expands HCV NS3/4A Protease Selection
AnaSpec, Eurogentec Group is pleased to announce the expansion of their NS3/4A protease selection to include proteases from genotypes 1a, 1b, 2a, 3a and 4d. These recombinant HCV NS3/4A proteases are highly active and can be used with the SensoLyte® 490, 520, or 620 HCV Protease Assay Kits for... - December 22, 2010 - AnaSpec, EGT Group
Anti-5-Methylcytidine Antibody from AnaSpec - Most Cited
AnaSpec, Eurogentec Group is pleased to offer anti-5-methylcytidine (Clone 33D3), Eurogentec’s most popular monoclonal antibody, for use in epigenetics research. 5-Methylcytidine is a modified base found in the DNA of plants and vertebrate. DNA methylation is a post-replication process... - December 11, 2010 - AnaSpec, EGT Group
AnaSpecs Offers Dyes for Labeling Amine- and Thiol-Modified Oligos
AnaSpec is pleased to highlight their own proprietary HiLyte Fluor dyes for labeling amine and thiol modified oligonucleotides from AnaSpec’s wide collection of amine and thiol reactive 6-isomeric dyes of fluoresceins and rhodamines. Fluorescent dye-labeled oligos are widely used as primers... - December 11, 2010 - AnaSpec, EGT Group
RayBiotech Renews Biomarker Discovery Grants for 2011
RayBiotech, Inc., announced today it will renew its Biomarker Discovery Pilot Grant program for 2011. RayBiotech will accept applications for pilot grants beginning in early 2011. Winning applicants will be eligible for restricted grants of $5,000 to $20,000 worth of RayBiotech products and/or services. This is the second year RayBiotech has sponsored these grants to demonstrate the application of antibody-based products to biomarker discovery. - December 04, 2010 - RayBiotech, Inc
GenScript Received OLAW (Office of Laboratory Animal Welfare) Approval for Animal Welfare Assurance
GenScript received the approval of Animal Welfare Assurance for its animal facility on 9 Nov, 2010. This approval accentuates the responsibilities and procedures of GenScript regarding the care and use of laboratory animals. - November 24, 2010 - GenScript USA Inc.
AnaSpec Introduces Anti-MOG (1-125), Mouse Monoclonal
Being the first in the industry to provide a whole suite of reagents and assay kits for the advancement of MS research, AnaSpec is pleased to announce the release of the mouse monoclonal Anti-MOG (1-125). Anti-MOG monoclonal antibody was produced by immunizing Balb/c mice with recombinant MOG... - November 14, 2010 - AnaSpec, EGT Group